Related Experiment Video
Updated: Jun 28, 2026
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
Amnestic MCI future clinical status prediction using baseline MRI features
Simon Duchesne1, Christian Bocti, Kathy De Sousa
1Radiology Department, Université Laval, Québec, Canada. duchesne@ieee.org
Abstract:
Amnestic mild cognitive impairment (aMCI) individuals are known to be at risk for progression to clinically probable Alzheimer's disease (AD). The objective of this work is to measure the accuracy of an automated classification technique based on clinical-quality, single time-point structural magnetic resonance imaging (MRI) scans for the retrospective prediction of future clinical status in aMCI. Thirty-one aMCI research subjects were followed with annual clinical reassessment after baseline MRI. Twenty subjects progressed to probable AD within an average 2.2 (1.4) years [mean age 76.6 (4.7) years, MMSE 27.1 (2.3)], while 11 remained non-demented on average 5.6 (2.6) years after baseline [mean age 73.3 (7.2) years, MMSE 28.2 (1.8)]. Leave-one-out classification was performed within a multidimensional MRI feature space built from intensity and local volume estimate data of a reference group of 75 probable AD and 75 age-matched control subjects. Prediction using aMCI data reached 81% accuracy, 70% sensitivity and 100% specificity. This automated and objective method has potential in helping predict future clinical status in aMCI.
Insights
An automated method using MRI scans can predict Alzheimer's disease progression in individuals with mild cognitive impairment. This technique achieved 81% accuracy, offering a valuable tool for early detection and patient management.
Area of Science:
- Neuroimaging
- Neurology
- Biomedical Engineering
Background:
- Amnestic mild cognitive impairment (aMCI) is a precursor to Alzheimer's disease (AD).
- Predicting progression from aMCI to AD is crucial for timely intervention.
- Current prediction methods may lack objectivity or require longitudinal data.
Purpose of the Study:
- To evaluate an automated classification technique for predicting future AD diagnosis in aMCI patients.
- To assess the accuracy of structural MRI scans for retrospective clinical status prediction.
- To determine the utility of single time-point MRI data in forecasting AD progression.
Main Methods:
- Utilized structural magnetic resonance imaging (MRI) from 31 aMCI subjects.
- Employed a leave-one-out classification within a multidimensional MRI feature space.
- Feature space derived from intensity and local volume estimates from AD and control subjects.
Main Results:
- The automated MRI classification achieved 81% accuracy in predicting future clinical status.
- Sensitivity was 70%, and specificity reached 100% for predicting progression to probable AD.
- Progression to AD occurred within an average of 2.2 years for 20 subjects.
Conclusions:
- Automated, single time-point structural MRI analysis is a viable method for predicting AD progression in aMCI.
- The technique demonstrates high accuracy and specificity, offering an objective tool.
- This approach holds potential for aiding clinical decision-making and patient management in aMCI.
